TD Asset Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.12M Buy
158,270
+40,026
+34% +$2.31M 0.01% 654
2025
Q1
$6.89M Buy
118,244
+14,044
+13% +$818K 0.01% 727
2024
Q4
$8.39M Buy
104,200
+16,446
+19% +$1.32M 0.01% 682
2024
Q3
$6.98M Sell
87,754
-16,394
-16% -$1.3M 0.01% 715
2024
Q2
$6.36M Sell
104,148
-78,642
-43% -$4.8M 0.01% 708
2024
Q1
$9.03M Sell
182,790
-31,426
-15% -$1.55M 0.01% 647
2023
Q4
$8.98M Sell
214,216
-45,600
-18% -$1.91M 0.01% 638
2023
Q3
$8.52M Buy
259,816
+107,797
+71% +$3.54M 0.01% 615
2023
Q2
$5.37M Buy
152,019
+14,140
+10% +$500K 0.01% 724
2023
Q1
$3.92M Buy
137,879
+6,051
+5% +$172K ﹤0.01% 802
2022
Q4
$5.48M Buy
131,828
+1,600
+1% +$66.5K 0.01% 730
2022
Q3
$5.27M Sell
130,228
-41,582
-24% -$1.68M 0.01% 738
2022
Q2
$5.62M Sell
171,810
-12,236
-7% -$400K 0.01% 742
2022
Q1
$6.44M Buy
184,046
+152,308
+480% +$5.33M 0.01% 765
2021
Q4
$794K Buy
31,738
+4,275
+16% +$107K ﹤0.01% 1319
2021
Q3
$1.05M Buy
+27,463
New +$1.05M ﹤0.01% 1241